Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lowe

Showing results (681-690 of 755) with videos related to

Pageof 76
Sort By:
Cell Reports|January 9, 2025
Human TRMT1 and TRMT1L paralogs ensure the proper modification state, stability, and function of tRNAsKejia Zhang, Aidan C Manning, Jenna M Lentini, et al.
Scientific Reports|June 21, 2024
Author Correction: Early human occupation of Australia's eastern seaboardShaun Adams, Kasih Norman, Justine Kemp, et al.
Plos Medicine|October 19, 2022
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19David M Lowe, Li-An K Brown, Kashfia Chowdhury, et al.
JCI Insight|December 19, 2023
Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativaMargaret M Lowe, Jarish N Cohen, Madison I Moss, et al.
The Journal of Biological Chemistry|December 8, 2018
Leucine-rich repeats and calponin homology containing 4 (Lrch4) regulates the innate immune responseJim J Aloor, Kathleen M Azzam, John J Guardiola, et al.
Elife|July 21, 2025
Layilin regulates Treg motility and suppressive capacity in skinVictoire Gouirand, Sean Clancy, Courtney Macon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 31, 2012
Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survivalP Thompson, I R Badell, M Lowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancerCatherine L Harper-Wynne, Nigel P M Sacks, Karyn Shenton, et al.
The Journal of Pediatrics|May 2, 2006
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Roberto Giugliani, Ida Schwartz, et al.
Science Translational Medicine|May 21, 2010
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV diseaseDavid Favre, Jeff Mold, Peter W Hunt, et al.
Pageof 76

Showing results (681-690 of 755) with videos related to

Sort By:
Pageof 76
Cell Reports|January 9, 2025
Human TRMT1 and TRMT1L paralogs ensure the proper modification state, stability, and function of tRNAsKejia Zhang, Aidan C Manning, Jenna M Lentini, et al.
Scientific Reports|June 21, 2024
Author Correction: Early human occupation of Australia's eastern seaboardShaun Adams, Kasih Norman, Justine Kemp, et al.
Plos Medicine|October 19, 2022
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19David M Lowe, Li-An K Brown, Kashfia Chowdhury, et al.
JCI Insight|December 19, 2023
Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativaMargaret M Lowe, Jarish N Cohen, Madison I Moss, et al.
The Journal of Biological Chemistry|December 8, 2018
Leucine-rich repeats and calponin homology containing 4 (Lrch4) regulates the innate immune responseJim J Aloor, Kathleen M Azzam, John J Guardiola, et al.
Elife|July 21, 2025
Layilin regulates Treg motility and suppressive capacity in skinVictoire Gouirand, Sean Clancy, Courtney Macon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 31, 2012
Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survivalP Thompson, I R Badell, M Lowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancerCatherine L Harper-Wynne, Nigel P M Sacks, Karyn Shenton, et al.
The Journal of Pediatrics|May 2, 2006
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Roberto Giugliani, Ida Schwartz, et al.
Science Translational Medicine|May 21, 2010
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV diseaseDavid Favre, Jeff Mold, Peter W Hunt, et al.
Pageof 76